Skip to main content
Log in

Myocardial content of selected elements in experimental anthracycline-induced cardiomyopathy in rabbits

  • Published:
Biometals Aims and scope Submit manuscript

Abstract

Cardiotoxicity represents the main drawback of clinical usefulness of anthracycline antineoplastic drugs. In this study, a content of selected elements (Ca, Mg, K, Se, Fe) in the post-mortem removed samples of the myocardial tissue was studied in three groups of rabbits: 1) control group (i.v. saline; n = 10); 2) daunorubicin-receiving animals (DAU; 3 mg/kg, i.v; n=11); 3) animals receiving cardioprotective iron-chelating agent dexrazoxane (DEX; 60 mg/kg, i.p.; n=5) prior to DAU. Drugs were administered once weekly for 10 weeks. 5–7 days after the last administration, cardiac left ventricular contractility (dP/dtmax) was significantly decreased in DAU-treated animals (745 ± 69 versus 1245 ± 86 kPa/s in the control group; P < 0.05), while in the DEX+DAU group it was insignificantly increased (1411 ± 77 kPa/s). Of the myocardial elements’ content studied, a significant increase in total Ca against control (16.2 ± 2.4 versus 10.6 ± 0.9 μg/g of dry tissue; P < 0.05) was determined in the DAU-group, which was accompanied with significant decreases in Mg and K. In the heart tissue of DEX-pretreated animals, no significant changes of elements’ content were found as compared to controls, while the Ca content was in these animals significantly lower than in the DAU group (9.1 ± 0.4 versus 16.2 ± 2.4 μg/g; P < 0.05). Hence, in this study we show that systolic heart failure induced by chronic DAU administration is primarily accompanied by persistent calcium overload of cardiac tissue and the protective action of DEX is associated with the restoration of normal myocardial Ca content.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • M Adamcova V Pelouch V Gersl J Kaplanova Y Mazurova T Simunek I Klimtova R. Hrdina (2003) ArticleTitleProtein profiling in daunorubicin-induced cardiomyopathy Gen Physiol Biophys 22 411–419

    Google Scholar 

  • KP Burton AC Morris KD Massey LM Buja HK Hagler (1990) ArticleTitleFree radicals alter ionic calcium levels and membrane phospholipids in cultured rat ventricular myocytes J Mol Cell Cardiol 22 1035–1047

    Google Scholar 

  • JL Buss BB Hasinoff (1993) ArticleTitleThe one-ring open hydrolysis product intermediates of the cardioprotective agent ICRF-187 (dexrazoxane) displace iron from iron-anthracycline complexes Agents Actions 40 86–95

    Google Scholar 

  • P Calabresi BA. Chabner (2001) Chemotherapy of neoplastic diseases JG Hardman LE Limbird (Eds) Goodman & Gilman’s The pharmacological basis of therapeutics EditionNumber10 McGraw-Hill New York 1381–1459

    Google Scholar 

  • WH Cheng YS Ho BA Valentine DA Ross GF Combs SuffixJr XG Lei (1998) ArticleTitleCellular glutathione peroxidase is the mediator of body selenium to protect against paraquat lethality in transgenic mice J Nutr 128 1070–1076

    Google Scholar 

  • M Chiesi G. Inesi (1981) ArticleTitleMg 2+and Mn 2+ modulation of Ca2+ transport and ATPase activity in sarcoplasmic reticulum vesicles Arch Biochem Biophys 208 586–592

    Google Scholar 

  • P. Delva (2003) ArticleTitleMagnesium and heart failure Mol Aspects Med 24 79–105

    Google Scholar 

  • JH. Doroshow (1983) ArticleTitleAnthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase Cancer Res 43 543–551

    Google Scholar 

  • V Geršl R. Hrdina (1994) ArticleTitleNoninvasive polygraphic cardiac changes in daunorubicin-induced cardiomyopathy in rabbits Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove 37 49–55

    Google Scholar 

  • L Gille H. Nohl (1997) ArticleTitleAnalyses of the molecular mechanism of adriamycin-induced cardiotoxicity Free Radic Biol Med 23 775–782

    Google Scholar 

  • I Halili-Rutman C Hershko G Link AJ Rutman A. Shainberg (1997) ArticleTitleInhibition of calcium accumulation by the sarcoplasmic reticulum: a putative mechanism for the cardiotoxicity of adriamycin Biochem Pharmacol 54 211–214

    Google Scholar 

  • MC Haigney S Wei S Kaab E Griffiths R Berger R Tunin D Kass WG Fisher B Silver H. Silverman (1998) ArticleTitleLoss of cardiac magnesium in experimental heart failure prolongs and destabilizes repolarization in dogs J Am Coll Cardiol 31 701–706

    Google Scholar 

  • BB Hasinoff K Hellmann EH Herman VJ. Ferrans (1998) ArticleTitleChemical, biological and clinical aspects of dexrazoxane and other bisdioxopiperazines Curr Med Chem 5 1–28

    Google Scholar 

  • EH Herman VJ. Ferrans (1998) ArticleTitlePreclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity Semin Oncol 25 15–21

    Google Scholar 

  • SR Holmberg DV Cumming Y Kusama DJ Hearse PA Poole-Wilson MJ Shattock AJ. Williams (1991) ArticleTitleReactive oxygen species modify the structure and function of the cardiac sarcoplasmic reticulum calcium-release channel Cardioscience 2 19–25

    Google Scholar 

  • SR Holmberg AJ. Williams (1990) ArticleTitlePatterns of interaction between anthraquinone drugs and the calcium-release channel from cardiac sarcoplasmic reticulum Circ Res 67 272–283

    Google Scholar 

  • M Horie H Irisawa A. Noma (1987) ArticleTitleVoltage-dependent magnesium block of adenosine-triphosphate-sensitive potassium channel in guinea-pig ventricular cells J Physiol 387 251–272

    Google Scholar 

  • R Hrdina V Gersl I Klimtova T Simunek J Machackova M. Adamcova (2000) ArticleTitleAnthracycline-induced cardiotoxicity Acta Medica (Hradec Kralove) 43 75–82 Occurrence Handle1:CAS:528:DC%2BD3cXnvV2lu7Y%3D

    CAS  Google Scholar 

  • AR Imondi P Della Torre G Mazue TM Sullivan TL Robbins LM Hagerman A Podesta G Pinciroli (1996) ArticleTitleDose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs Cancer Res 56 4200–4204

    Google Scholar 

  • K Ishihara T Mitsuiye A Noma M. Takano (1989) ArticleTitleThe Mg2+ block and intrinsic gating underlying inward rectification of the K+ current in guinea-pig cardiac myocytes J Physiol 419 297–320

    Google Scholar 

  • I Klimtová T Simunek Y Mazurova R Hrdina V Gersl M. Adamcova (2002) ArticleTitleComparative study of chronic toxic effects of daunorubicin and doxorubicin in rabbits Hum Exp Toxicol 21 649–657

    Google Scholar 

  • JC Kwok DR. Richardson (2000) ArticleTitleThe cardioprotective effect of the iron chelator dexrazoxane (ICRF-187) on anthracycline-mediated cardiotoxicity Redox Rep 5 317–324 Occurrence Handle10.1179/135100000101535898 Occurrence Handle1:CAS:528:DC%2BD3MXjvVSrug%3D%3D Occurrence Handle11140743

    Article  CAS  PubMed  Google Scholar 

  • JC Kwok DR. Richardson (2003) ArticleTitleAnthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: inhibition of the ferritin iron mobilization pathway Mol Pharmacol 63 849–861

    Google Scholar 

  • G Minotti P Menna E Salvatorelli G Cairo L. Gianni (2004) ArticleTitleAnthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity Pharmacol Rev 56 185–229

    Google Scholar 

  • RD Olson PS. Mushlin (1990) ArticleTitleDoxorubicin cardiotoxicity: analysis of prevailing hypotheses FASEB J 4 3076–3086 Occurrence Handle1:CAS:528:DyaK3MXhs12ktA%3D%3D Occurrence Handle2210154

    CAS  PubMed  Google Scholar 

  • IN Pessah EL Durie MJ Schiedt I. Zimanyi (1990) ArticleTitleAnthraquinone-sensitized Ca 2+ release channel from rat cardiac sarcoplasmic reticulum: possible receptor-mediated mechanism of doxorubicin cardiomyopathy Mol Pharmacol 37 503–514

    Google Scholar 

  • S Rajagopalan PM Politi BK Sinha CE. Myers (1988) ArticleTitleAdriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity Cancer Res 48 4766–4769

    Google Scholar 

  • MA Ralston MR Murnane RE Kelley RA Altschuld DV Unverferth CV. Leier (1989) ArticleTitleMagnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure Circulation 80 573–580

    Google Scholar 

  • DR. Richardson (1997) ArticleTitlePotential of iron chelators as effective antiproliferative agents Can J Physiol Pharmacol 75 1164–1180

    Google Scholar 

  • A Romani A. Scarpa (1992) ArticleTitleRegulation of cell magnesium Arch Biochem Biophys 298 1–12

    Google Scholar 

  • NE Saris E Mervaala H Karppanen JA Khawaja A. Lewenstam (2000) ArticleTitleMagnesium An update on physiological, clinical and analytical aspects Clin Chim Acta 294 1–26

    Google Scholar 

  • S Sartori I Nielsen D Tassinari A Maestri V. Abbasciano (1991) ArticleTitleIntracellular magnesium concentrations and acute anthracycline-induced cardiotoxicity Br J Cancer 64 785–787

    Google Scholar 

  • KJ Schimmel DJ Richel RB Brink Particlevan den HJ Guchelaar (2004) ArticleTitleCardiotoxicity of cytotoxic drugs Cancer Treat Rev 30 181–191 Occurrence Handle10.1016/j.ctrv.2003.07.003

    Article  Google Scholar 

  • K Shan AM Lincoff JB. Young (1996) ArticleTitleAnthracycline-induced cardiotoxicity Ann Intern Med 125 47–58 Occurrence Handle1:STN:280:BymB2crgvVU%3D Occurrence Handle8644988

    CAS  PubMed  Google Scholar 

  • SM Swain P. Vici (2004) ArticleTitleThe current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review J Cancer Res Clin Oncol 130 1–7

    Google Scholar 

  • TF Tam R Leung-Toung W Li Y Wang K Karimian M. Spino (2003) ArticleTitleIron chelator research: past, present, and future Curr Med Chem 10 983–995

    Google Scholar 

  • K Temma A Chugun T Akera Y Hara T Sasaki H. Kondo (1997) ArticleTitleCa 2+ overloading causes the negative inotropic effect of doxorubicin in myocytes isolated from guinea-pig hearts Eur J Pharmacol 322 235–242

    Google Scholar 

  • LR Wiseman CM. Spencer (1988) ArticleTitleDexrazoxane A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy Drugs 56 385–403

    Google Scholar 

  • X Yin H Wu Y Chen YJ. Kang (1998) ArticleTitleInduction of antioxidants by adriamycin in mouse heart Biochem Pharmacol 56 87–93

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tomáš Šimůnek.

Additional information

Published online: March 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Šimůnek, T., Štěrba, M., Holečková, M. et al. Myocardial content of selected elements in experimental anthracycline-induced cardiomyopathy in rabbits. Biometals 18, 163–169 (2005). https://doi.org/10.1007/s10534-004-4491-7

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10534-004-4491-7

Keywords

Navigation